The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(5-((2-oxo-5-p-tolylfuran-3(2H)-ylidene)methyl)furan-2-yl)benzoic acid ID: ALA2295999
PubChem CID: 1920904
Max Phase: Preclinical
Molecular Formula: C23H16O5
Molecular Weight: 372.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C2=C/C(=C\c3ccc(-c4cccc(C(=O)O)c4)o3)C(=O)O2)cc1
Standard InChI: InChI=1S/C23H16O5/c1-14-5-7-15(8-6-14)21-13-18(23(26)28-21)12-19-9-10-20(27-19)16-3-2-4-17(11-16)22(24)25/h2-13H,1H3,(H,24,25)/b18-12+
Standard InChI Key: LFMGAYSGKKKIHC-LDADJPATSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
18.4844 -19.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4833 -20.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1913 -20.6718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9010 -20.2624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8982 -19.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1896 -19.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7739 -19.0363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7737 -18.2192 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0663 -19.4451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6071 -19.0285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3546 -19.3593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8999 -18.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4869 -18.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6878 -18.2186 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8147 -17.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3302 -16.6361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5785 -15.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9144 -15.3822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2562 -15.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5136 -16.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3542 -15.6015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4793 -15.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3054 -14.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5275 -14.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9227 -15.1195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1011 -15.9213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8788 -16.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1436 -14.8729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 9 2 0
1 7 1 0
11 12 1 0
10 11 2 0
12 13 2 0
13 14 1 0
14 10 1 0
5 10 1 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 16 1 0
17 21 2 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
19 22 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.38Molecular Weight (Monoisotopic): 372.0998AlogP: 4.93#Rotatable Bonds: 4Polar Surface Area: 76.74Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.95CX Basic pKa: ┄CX LogP: 4.69CX LogD: 1.50Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -0.39
References 1. Park H, Kyung A, Lee H, Kang S, Yoon T, Ryu SE, Jeong DG. (2013) Virtual screening and biochemical evaluation of the inhibitors of dual-specificity phosphatase 26, 22 (8): [10.1007/s00044-012-0405-3 ]